从基因到治疗:在精准医学时代的垂体腺瘤
Corneliu Toader1,2, Nicolaie Dobrin3, Catalina-Ioana Tataru4,5
1Department of Neurosurgery, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Biomedicines
|January 26, 2024
概括
本综述分析了垂体腺瘤,探索了治疗方法和生物标志物的关键作用. 基因组和表观基因组分析的进步为瘤发育和个性化治疗策略提供了新的见解,以改善患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 内分泌学 在内分泌学.
- 分子病理学分子病理学
背景情况:
- 垂体腺瘤是复杂的大脑瘤,具有不同的临床表现.
- 目前的治疗包括手术,放射治疗和化疗,往往需要多模式的方法.
研究的目的:
- 为下垂体腺瘤提供全面的综述,重点关注治疗方式和生物标志物的作用.
- 突出分子分析的进步,以了解病变发生和改善患者的治疗结果.
主要方法:
- 关于垂体腺瘤研究的文献综述.
- 对基因组,表观基因组和转录基因组数据的分析.
- 评估瘤免疫微环境的作用.
主要成果:
- 生物标志物对于垂体腺瘤的风险评估,诊断,预后和监测至关重要.
- 表观遗传因素和转录基因变化显著影响瘤亚型.
- 瘤免疫微环境影响瘤的行为和治疗反应.
结论:
- 分子病理学和生物标志物发现的进步对于有效的垂体腺瘤管理至关重要.
- 需要进一步的研究来将科学发现转化为改善患者护理的临床进展.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


